id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1999-D-0049-0004,FDA,FDA-1999-D-0049,Guidance for Industry on Changes to an Approved New Drug Application or Abbreviated New Drug Application; Availability; Correction,Notice,Correction,2004-04-27T04:00:00Z,2004,4,2004-04-23T04:00:00Z,,2025-08-05T16:12:58Z,04-9324,0,0,09000064804a6057
FDA-1999-D-0049-0003,FDA,FDA-1999-D-0049,Guidance for Industry on Changes to an Approved NDA or ANDA; Availability,Notice,Notice of Data Availability,2004-04-08T04:00:00Z,2004,4,2004-04-07T04:00:00Z,,2025-08-05T16:08:04Z,04-7533,0,0,09000064804a6056
FDA-1999-D-0049-0002,FDA,FDA-1999-D-0049,Guidance for Industry Changes to an Approved NDA or ANDA,Notice,Guidance,2004-04-08T04:00:00Z,2004,4,,,2024-11-07T21:52:49Z,,1,0,09000064804a6055
FDA-1999-D-0049-0001,FDA,FDA-1999-D-0049,Changes to an Approved NDA or ANDA; Proposed Rule and Draft Companion Guidance; Public Meeting,Notice,NM-Notice of Meeting,1999-08-05T00:00:00Z,1999,8,,,2025-05-21T22:37:52Z,,0,0,09000064804a6017